SCD1 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CAY 10566 | 944808-88-2 | sc-205109 sc-205109A sc-205109B | 1 mg 5 mg 25 mg | $117.00 $512.00 $1527.00 | 4 | |
CAY 10566 functions as a selective inhibitor of SCD1, exhibiting unique molecular interactions that target the enzyme's active site. Its structural conformation promotes specific binding, influencing lipid metabolism pathways by modulating fatty acid desaturation. The compound's kinetic profile reveals a rapid onset of action, while its solubility characteristics enable effective engagement with lipid bilayers, facilitating in-depth exploration of metabolic regulation mechanisms. | ||||||
PluriSln 1 | 91396-88-2 | sc-397044 sc-397044A | 10 mg 50 mg | $99.00 $415.00 | ||
PluriSln 1 acts as a selective SCD1 inhibitor, characterized by its ability to disrupt enzyme-substrate interactions through unique steric hindrance. This compound alters lipid biosynthesis pathways by stabilizing intermediate conformations, thereby affecting reaction kinetics. Its distinctive hydrophobic properties enhance membrane permeability, allowing for targeted modulation of lipid profiles. The compound's reactivity with specific functional groups further underscores its role in metabolic regulation. | ||||||
5-chloro-1′-[(2-fluorophenyl)methyl]-2,2′,5′-trioxo-spiro[3H-indole-3,3′-pyrrolidine-1(2H)-acetic acid | 916046-55-4 | sc-205132 sc-205132A | 1 mg 5 mg | $70.00 $320.00 | ||
A potent SCD1 inhibitor that exhibits anti-inflammatory effects by modulating lipid metabolism. | ||||||
A 922500 | 959122-11-3 | sc-203793 | 10 mg | $270.00 | 2 | |
A potent and selective SCD1 inhibitor that has been investigated for its potential use in metabolic disorders, such as obesity and non-alcoholic fatty liver disease. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
While primarily known as an inhibitor of NF-κB activation, BAY 11-7085 has also been reported to inhibit SCD1 activity, leading to alterations in lipid metabolism. | ||||||